Penicillium genus as a source for anti-leukemia compounds: an overview from 1984 to 2020

Penicillium is a widely explored genus due to its chemical diversity and associated biological properties; in addition, it represents an important source for cytotoxic compounds with good application perspectives. Based on these aspects, in this review, Penicillium compounds that presented activity...

Full description

Saved in:
Bibliographic Details
Published in:Leukemia & lymphoma 2021-07, Vol.62 (9), p.2079-2093
Main Authors: de Carvalho, Ana Calheiros, Ogawa, Claudio Yoshio, De Camillis Rodrigues, Luiza, de Medeiros, Lívia Soman, Veiga, Thiago André Moura
Format: Article
Language:English
Subjects:
Leukemia
natural products
L-asparaginase
Penicillium
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Penicillium is a widely explored genus due to its chemical diversity and associated biological properties; in addition, it represents an important source for cytotoxic compounds with good application perspectives. Based on these aspects, in this review, Penicillium compounds that presented activity against human leukemia cell lines are being listed and discussed. For this, a careful bibliographic survey was carried out in the main electronic databases, i.e. Scopus, SciFinder, Web of Science and Pubmed. Between 1984 and 2020, thirty seven original papers were selected, when using the search terms Penicillium and leukemia. The occurrence of l-asparaginase produced by some Penicillium spp. was also highlighted since this enzyme is being employed for acute lymphoblastic leukemia and lymphosarcoma therapies. Therefore, this overview aims to demonstrate the potential of metabolites biosynthesized by Penicillium fungi which can be applied in human leukemia therapies and opportunities for designing new lead compounds.
ISSN:1042-8194
1029-2403
DOI:10.1080/10428194.2021.1897804